Clinical Trial Update: A Study of APL-10456-Vaccine [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 study of APL-10456-Vaccine by Apollo Therapeutics Ltd is recruiting for rhinovirus-related indications (common cold).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• APL-10456-Vaccine

Snippet

Sponsor: Apollo Therapeutics Ltd | Conditions: Rhinovirus | EARLY_Phase 1 | Status: RECRUITING